PROTAC BRD9 Degrader-4
Product Specifications
UNSPSC Description
PROTAC BRD9 Degrader-4 is a BRD9 bifunctional degrader for researching cancer.
Target Antigen
PROTACs
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/protac-brd9-degrader-4.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCCCN1C=C(C2=CC(OC)=C(C=C2)O[C@@H]3[C@H](CN(CC3)CC4CCN(CC4)C(C5=CC(N6C(NC(CC6)=O)=O)=C(C=C5)OC)=O)F)C7=CC=NC=C7C1=O
Molecular Weight
768.87
References & Citations
[1]Sabnis RW, et al. BRD9 Bifunctional Degraders for Treating Cancer. ACS Med. Chem. Lett. 2021 Nov 6.
Shipping Conditions
Blue Ice
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145403/PROTAC-BRD9-Degrader-4-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145403/PROTAC-BRD9-Degrader-4-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2633632-34-3
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
(2R,3S)-6-Oxo-2,3-diphenyl-4-morpholinecarboxylic Acid tert-Butyl Ester
